NRC draft guidance may complicate patient access to cancer treatment

August 18, 2023, 8:53AMNuclear News

A Nuclear Regulatory Commission draft regulatory guide—DG-8061, “Release of Patients Administered Radioactive Material”—proposes guidance on the release of patients after a medical procedure involving the administration of radiopharmaceuticals or the implantation of a sealed source. The guidance is intended to help licensees interpret NRC regulations designed to protect the people—family, friends, caregivers, or members of the general public—who may be in proximity to a patient who is discharged after receiving nuclear medicine treatment.

To continue reading, log in or create a free account!

Related Articles

Nieh confirmed for the NRC

November 19, 2025, 3:00PMNuclear News

Earlier today, the U.S. Senate officially confirmed Ho Nieh in a 66–32 vote to serve as a commissioner on the U.S. Nuclear Regulatory Commission through the remainder of a term that will...

New financing round benefits Valar

November 13, 2025, 3:00PMNuclear News

Hawthorne, Calif.–based reactor start-up Valar Atomics recently announced that it has raised $130 million in its Series A funding round, led by venture capital groups Snowpoint, Day One, and...

X-energy begins irradiation testing at INL

November 12, 2025, 3:01PMNuclear News

Advanced reactor and fuel developer X-energy has officially begun confirmatory irradiation testing at Idaho National Laboratory on its TRISO-X fuel. The testing, which is taking place over the...